CIK 0001926599 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Translational Development Acquisition Corp.
Sign in to watch- Ticker
- TDAC
- Exchange
- Nasdaq
- Industry
- Blank Checks
- FY end
- Dec 31
- Entity type
- operating
- Phone
- (413) 204-2769
- Business address
- 52 E 83RD ST., NEW YORK, NY, 10028
Securities
- TDAC Ordinary Shares Nasdaq
- TDACU Units Nasdaq
- TDACW Warrants Nasdaq
- 8-K Event Material agreement · Bylaws or fiscal year change · Shareholder vote results
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Unregistered share sale
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Derivatives Options or other derivatives
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · Regulation FD disclosure
- 10-Q Report Quarterly Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-K/A Report 10-K/A
- 10-K/A Report 10-K/A
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-K Report Annual Report
- 10-Q Report Quarterly Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event New debt or obligation · Other events
Page 2 of 4 · 80 filings